Cargando…
Responsiveness to PI3K and MEK Inhibitors in Breast Cancer. Use of a 3D Culture System to Study Pathways Related to Hormone Independence in Mice
BACKGROUND: A significant proportion of breast cancer patients face failure of endocrine therapy due to the acquisition of endocrine resistance. We have explored mechanisms involved in such disease progression by using a mouse breast cancer model that is induced by medroxyprogesterone acetate (MPA)....
Autores principales: | Polo, Maria Laura, Arnoni, Maria Victoria, Riggio, Marina, Wargon, Victoria, Lanari, Claudia, Novaro, Virginia |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2877092/ https://www.ncbi.nlm.nih.gov/pubmed/20520761 http://dx.doi.org/10.1371/journal.pone.0010786 |
Ejemplares similares
-
Activation of PI3K/Akt/mTOR signaling in the tumor stroma drives endocrine therapy-dependent breast tumor regression
por: Polo, María Laura, et al.
Publicado: (2015) -
AKT1 and AKT2 isoforms play distinct roles during breast cancer progression through the regulation of specific downstream proteins
por: Riggio, Marina, et al.
Publicado: (2017) -
Selective Eradication of Colon Cancer Cells Harboring PI3K and/or MAPK Pathway Mutations in 3D Culture by Combined PI3K/AKT/mTOR Pathway and MEK Inhibition
por: Atanasova, Velina S., et al.
Publicado: (2023) -
Alternative dosing of dual PI3K and MEK inhibition in cancer therapy
por: Jokinen, Elina, et al.
Publicado: (2012) -
The BA-BCS 2021: An Initial “Trial” for Integrating Basic Science and Medical Progress on Breast Cancer in a Latin-American Country
por: Kordon, Edith, et al.
Publicado: (2021)